Currently, treatment is available for the neovascular form of AMD (nAMD), consisting of intravitreal injections of anti-vascular endothelial growth factors anti-vascular endothelial growth factors (anti-VEGF). This evidence concerns the gene VEGFA and age-related macular degeneration.